-
InnoCare and Keymed Jointly Announce First Subject Dosed in Clinical Trial of CCR8 Monoclonal Antibody ICP-B05
PharmaSources
February 24, 2023
InnoCare Pharma and Keymed Biosciences that the first subject has been dosed in clinical trial of ICP-B05.
-
On sale with the unit price of CNY 12,375/bottle, Sugemalimab is planning to file for a third indication
PharmaSources/Yi
January 24, 2022
Recently, Sugemalimab (trade name: Cejemly®), Stone Pharma PD-L1 monoclonal antibody, is on sale in China. It is reported that its public retail price is CNY 12,375/bottle (600mg/20ml) (tax included).
-
Junshi’s Anti-PD-1 Drug Achieved Sales of RMB1.3 Billion in 2020
PharmaSources/Caicai
March 12, 2021
Junshi Biosciences has recently announced its 2020 annual performance preview, according to which, it achieved operating income of RMB1.595 billion, up 105.77% year on year, mainly thanks to the sales revenue growth of its anti-PD-1 drug.
-
Pharmaceutical News of the Week | CPhI.CN - R&D
PharmaSources/Caicai
August 06, 2020
Clinical trials were approved for recombinant human papillomavirus 9-valent vaccine (Pichia pastoris) and recombinant herpes zoster vaccine (CHO) jointly applied for by Shanghai Easyway and Ab&b Bio-Tech on July 27.
-
PK Hengrui! New indication of Merck's PD-1 monoclonal antibody Keytruda esophageal cancer is about to be approved in China
CPhI.CN
June 17, 2020
New indication of Merck's PD-1 monoclonal antibody Keytruda esophageal cancer is about to be approved in China
-
FDA Approves Monoclonal Antibody to Treat Arthritis in Cats
drugs.com
January 13, 2022
Arthritis can keep a cat from doing many of the things that kitties love to do. But now there's hope: The first treatment to ease arthritis pain in cats has been approved by the U.S. Food and Drug Administration.
-
GSK Singapore Announces Additional Supply of Monoclonal Antibody Sotrovimab to the Government of Singapore
prnasia
December 07, 2021
GlaxoSmithKline Singapore announced an agreement with the Government of Singapore to supply additional doses of sotrovimab. Sotrovimab is an investigational single-dose monoclonal antibody developed in partnership...
-
Akeso is rapidly advancing the clinical study of the PD-1/CTLA-4 bispecific antibody Cadonilimab combined with TIGIT monoclonal antibody for the teratment of solid tumors
prnasia
October 22, 2021
Akeso, one of leading Chinese pharmaceutical innovation company announces that the first patient was dosed in a phase I clinical trial of the Company's independently developed TIGIT monoclonal antibody (AK127)...
-
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002
prnasia
September 28, 2021
Transcenta Holding Limited ("Transcenta"), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics...
-
FDA Approves Third COVID-19 Antibody Treatment for Emergency Use
drugs
May 31, 2021
A third antibody treatment designed to keep high-risk COVID-19 patients from being hospitalized was approved for emergency use by the U.S. Food and Drug Administration on Wednesday.